News
Rhea-AI Summary
ANEW MEDICAL (NASDAQ: WENA) has secured a key patent in Europe (EP3377091B1) for its secreted Klotho gene (s-KL) and gene delivery systems, targeting neurodegenerative diseases like dementia and Alzheimer's. This patent complements earlier approvals in China and Hong Kong. The intellectual property was exclusively licensed from institutions in Barcelona, Spain. ANEW plans to leverage this patent for product development and expand into Asian markets starting in 2024. CEO Dr. Joseph Sinkule emphasized the potential of s-KL for cell and gene therapy in treating neurological disorders, noting its critical role in brain function and neurological health.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
119.39%
Tags
FAQ
What is the current stock price of ANEW MEDICAL (WENA)?
ANEW MEDICAL (WENA) last closed at $0.726.
What is the market cap of ANEW MEDICAL (WENA)?
The market cap of ANEW MEDICAL (WENA) is approximately $15.4M.